Filing Details
- Accession Number:
- 0001225208-23-005593
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-08 21:54:11
- Reporting Period:
- 2023-05-05
- Accepted Time:
- 2023-05-08 21:54:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1099800 | Edwards Lifesciences Corp | EW | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 364316614 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1196661 | Jr E Donald Bobo | One Edwards Way Irvine CA 92614 | Cvp,Strategy/Corp Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-05-05 | 5,635 | $88.63 | 56,225 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-05-07 | 4,767 | $0.00 | 60,992 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-05-07 | 2,968 | $88.74 | 58,024 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2023-05-08 | 1,399 | $88.74 | 56,625 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Rights | Disposition | 2023-05-07 | 4,767 | $0.00 | 4,767 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,308 | 2023-05-07 | 2027-05-06 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 38,444 | Indirect | 401(k) |
| Common Stock | 111,605 | Indirect | By Trust |
Footnotes
- On May 7, 2020, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2023, the Compensation Committee of the Board of Directors determined that 78.48% of the target number of shares would vest as of May 1, 2023, and the actual number of shares vested are reflected on this Form 4.
Billionaire Hedge Funds
